ADMA Biologics Inc (ADMA)
Operating profit margin
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Operating income | US$ in thousands | 21,632 | -39,365 | -58,374 | -64,915 | -41,424 |
| Revenue | US$ in thousands | 258,215 | 154,080 | 80,943 | 42,220 | 29,349 |
| Operating profit margin | 8.38% | -25.55% | -72.12% | -153.75% | -141.14% |
December 31, 2023 calculation
Operating profit margin = Operating income ÷ Revenue
= $21,632K ÷ $258,215K
= 8.38%
The operating profit margin of ADMA Biologics Inc has shown a significant improvement over the past five years, with the margin increasing from negative values in 2019 and 2020 to positive results in 2021, 2022, and 2023. In 2023, the operating profit margin improved to 8.38%, reflecting the company's ability to generate profits from its core operations. This improvement indicates that ADMA Biologics has been able to better control its operating expenses and increase the efficiency of its operations compared to previous years. It is important for investors and stakeholders to monitor this trend to assess the company's profitability and operational performance over time.
Peer comparison
Dec 31, 2023